SCHEMBL5590071

SCHEMBL5590071

CCCc1c(O)c(O)c(CCC)c2c1Oc1cccc(Br)c1O2

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
CYP1A1 P04798 1/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 2/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590033 0.91 CYP1A1 (0.40) ALDH1A1CYP1A1KDM4EHPGD
SCHEMBL6252702 0.89 ALDH1A1 (0.39) ALDH1A1CYP1A1KDM4EHPGDGAA
SCHEMBL5589007 0.88 GABRA1 (0.33)
SCHEMBL5588626 0.83 GABRA1 (0.36) ALDH1A1CYP1A1KDM4EHPGD
SCHEMBL5587181 0.82 CYP1A1 (0.41) ALDH1A1CYP1A1KDM4EHPGDGAA
SCHEMBL5586963 0.82 ALOX15 (0.32)
SCHEMBL5588306 0.82 AHR (0.50) ALDH1A1CYP1A1KDM4EHPGD
SCHEMBL5590507 0.77 ALOX15 (0.33)
SCHEMBL5587764 0.76 AHR (0.50)
SCHEMBL5587102 0.76 AHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALDH1A1 2181/4885CYP1A1 1341/4885KDM4E 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.